{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:47:51Z","timestamp":1783032471855,"version":"3.54.6"},"reference-count":59,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T00:00:00Z","timestamp":1517616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The aim of this review is to investigate, whether there is a possible link between vitamin D supplementation and the reduction of blood pressure in hypertensive patients. The renin-angiotensin-aldosterone system is known for being deeply involved in cardiovascular tonus and blood pressure regulation. Hence, many of the pharmaceutical antihypertensive drugs inhibit this system. Interestingly, experimental studies in mice have indicated that vitamin D supplementation significantly lowers renin synthesis and blood pressure. It is conceivable that similar mechanisms may be found in the human organism. Regarding this, large-scale cross-sectional studies suggest the serum 25(OH)D-level to be inversely correlated to the prevalence of hypertension. However, randomized controlled trials (RCTs) have not found a clear association between vitamin D supplementation and improvements in hypertension. Nevertheless, the missing association of vitamin D and hypertension in clinical trials can be due to suboptimal study designs. There are hints that restoration of serum 25(OH)D levels during vitamin D therapy is essential to achieve possible beneficial cardiovascular effects. It is important to perform long-term trials with a short dose interval and a high bioavailability of supplementation. Taken together, more RCTs are required to further investigate if vitamin D can be beneficial for the reduction of blood pressure.<\/jats:p>","DOI":"10.3390\/ijms19020455","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T04:29:42Z","timestamp":1517804982000},"page":"455","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["The Impact of Vitamin D in the Treatment of Essential Hypertension"],"prefix":"10.3390","volume":"19","author":[{"given":"Christian","family":"Legarth","sequence":"first","affiliation":[{"name":"Institute of Biomedicine, Pharmacology, Aarhus University, Wilhelm Meyers All\u00e9 4, DK-8000 Aarhus C, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Grimm","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine, Pharmacology, Aarhus University, Wilhelm Meyers All\u00e9 4, DK-8000 Aarhus C, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Wehland","sequence":"additional","affiliation":[{"name":"Clinic for Plastic, Aesthetic and Hand Surgery, Otto von Guericke University, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauer","sequence":"additional","affiliation":[{"name":"Max Planck Institute for Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1120-0246","authenticated-orcid":false,"given":"Marcus","family":"Kr\u00fcger","sequence":"additional","affiliation":[{"name":"Clinic for Plastic, Aesthetic and Hand Surgery, Otto von Guericke University, Leipziger Str. 44, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,2,3]]},"reference":[{"key":"ref_1","unstructured":"(2017, October 30). A Global Brief on Hypertension. Available online: http:\/\/apps.who.int\/iris\/bitstream\/10665\/79059\/1\/WHO_DCO_WHD_2013.2_eng.pdf."},{"key":"ref_2","first-page":"13","article-title":"Vitamin D status and hypertension: A review","volume":"8","author":"Ke","year":"2015","journal-title":"Integr. Blood Press. Control."},{"key":"ref_3","first-page":"e1038","article-title":"Does Vitamin D Deficiency Lead to Hypertension?","volume":"9","author":"Mehta","year":"2017","journal-title":"Cureus"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Qi, D., Nie, X.L., Wu, S., and Cai, J. (2017). Vitamin D and hypertension: Prospective study and meta-analysis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0174298"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ajh.2010.199","article-title":"Vitamin D and the Prevention of Hypertension and Cardiovascular Diseases: A Review of the Current Evidence","volume":"24","author":"Geleijnse","year":"2011","journal-title":"Am. J. Hypertens."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/HYPERTENSIONAHA.109.140160","article-title":"Vitamin D and Hypertension: Current Evidence and Future Directions","volume":"56","author":"Vaidya","year":"2010","journal-title":"Hypertension"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0140-6736(90)91073-J","article-title":"Dietary supplementation in elderly patients with fractured neck of the femur","volume":"335","author":"Delmi","year":"1990","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.amjms.2017.04.007","article-title":"Potenial Cardiovascular and Renal Protective Effects of Vitamin D and Coenzyme Q10 in l-NAME-Induced Hypertensive Rats","volume":"354","author":"Shamardl","year":"2017","journal-title":"Am. J. Med. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"19.e2","DOI":"10.1016\/j.jash.2008.08.001","article-title":"Prevalence, awareness, and control of arterial hypertension in Denmark","volume":"3","author":"Kronborg","year":"2009","journal-title":"J. Am. Soc. Hypertens."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Whelton, P.K., Carey, R.M., Aronow, W.S., Casey, D.E., Collins, K.J., Dennison Himmelfarb, C., DePalma, S.M., Gidding, S., Jamerson, K.A., and Jones, D.W. (2017). 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension.","DOI":"10.1161\/HYP.0000000000000066"},{"key":"ref_12","first-page":"216","article-title":"Resistance reconstructed estimation of total peripheral resistance from computationally derived cardiac output\u2014Biomed 2013","volume":"49","author":"Hill","year":"2013","journal-title":"Biomed. Sci. Instrum."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.116.303596","article-title":"The structural factor of hypertension: Large and small artery alterations","volume":"116","author":"Laurent","year":"2015","journal-title":"Circ. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fcvm.2016.00003","article-title":"Timeline of History of Hypertension Treatment","volume":"3","author":"Saklayen","year":"2016","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3317\/jraas.2004.034","article-title":"How do thiazide and thiazide-like diuretics lower blood pressure?","volume":"5","author":"Hughes","year":"2004","journal-title":"J. Renin Angiotensin Aldoster. Syst."},{"key":"ref_17","unstructured":"Br\u00f8sen, K., Simonsen, U., Kampmann, J.P., and Thirstrup, S. (2014). Basal Og Klinisk Farmakologi, FADL\u2019s Forlag. [5th ed.]."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1874467208666150507105845","article-title":"Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?","volume":"8","author":"Striessnig","year":"2015","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/FJC.0b013e3181ad207b","article-title":"Evolving mechanisms of action of beta blockers: Focus on nebivolol","volume":"54","author":"Mason","year":"2009","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/eurheartj\/ehs075","article-title":"Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: A meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients","volume":"33","author":"Bertrand","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1470320312443910","article-title":"The role of angiotensin receptor blockers in reducing the risk of cardiovascular disease","volume":"13","author":"Abramov","year":"2012","journal-title":"J. Renin Angiotensin Aldoster. Syst."},{"key":"ref_22","first-page":"21","article-title":"Direct renin inhibition: Focus on aliskiren","volume":"13","author":"Pool","year":"2007","journal-title":"J. Manag. Care Pharm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.coph.2010.04.001","article-title":"Vitamin D: Modulator of the immune system","volume":"10","author":"Baeke","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0024-3205(75)90256-8","article-title":"Nuclear and cytoplasmic binding components for vitamin D metabolites","volume":"16","author":"Brumbaugh","year":"1975","journal-title":"Life Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.abb.2012.04.001","article-title":"Where is the vitamin D receptor?","volume":"523","author":"Wang","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.beem.2013.06.001","article-title":"Determination of vitamin D and its metabolites","volume":"27","author":"Farrell","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Razzaque, M.S. (2017). Can adverse effects of excessive vitamin D supplementation occur without developing hypervitaminosis D?. J. Steroid Biochem. Mol. Biol.","DOI":"10.1016\/j.jsbmb.2017.07.006"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"29821","DOI":"10.1074\/jbc.M705495200","article-title":"1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter","volume":"282","author":"Yuan","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/ki.2008.452","article-title":"Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium","volume":"74","author":"Kong","year":"2008","journal-title":"Kidney Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1152\/ajpendo.00224.2004","article-title":"Cardiac hypertrophy in vitamin D receptor knockout mice: Role of the systemic and cardiac renin-angiotensin systems","volume":"288","author":"Xiang","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/01.HYP.25.2.250","article-title":"Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats","volume":"25","author":"Bruckschlegel","year":"1995","journal-title":"Hypertension"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1054-8807(01)00116-8","article-title":"Experimental diabetes and left ventricular hypertrophy: Effects of beta-receptor blockade","volume":"11","author":"Grimm","year":"2002","journal-title":"Cardiovasc. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.33549\/physiolres.930024","article-title":"Different expression of renin-angiotensin system components in hearts of normotensive and hypertensive rats","volume":"50","author":"Jurkovicova","year":"2001","journal-title":"Physiol. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0895-7061(02)02956-4","article-title":"Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy","volume":"15","author":"Rothermund","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/01.CIR.98.8.800","article-title":"Evidence that macrophages in atherosclerotic lesions contain angiotensin II","volume":"98","author":"Potter","year":"1998","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1210\/me.2011-1329","article-title":"Vitamin D receptor signaling inhibits atherosclerosis in mice","volume":"26","author":"Szeto","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1043-2760(03)00111-5","article-title":"The intrarenal renin-angiotensin system and diabetic nephropathy","volume":"14","author":"Carey","year":"2003","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"15561","DOI":"10.1038\/srep15561","article-title":"Chronic Activation of the Renin-Angiotensin System Induces Lung Fibrosis","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1038\/s41598-017-03474-6","article-title":"Chronic vitamin D deficiency induces lung fibrosis through activation of the renin-angiotensin system","volume":"7","author":"Shi","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1467-789X.2011.00942.x","article-title":"The renin-angiotensin system: A link between obesity, inflammation and insulin resistance","volume":"13","author":"Kalupahana","year":"2012","journal-title":"Obes. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.3892\/etm.2017.4404","article-title":"Effects of 1,25-dihydroxyvitamin D3 on the local bone renin-angiotensin system in a murine model of glucocorticoid-induced osteoporosis","volume":"13","author":"Shen","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00125-011-2100-1","article-title":"A novel role for vitamin D: Modulation of expression and function of the local renin-angiotensin system in mouse pancreatic islets","volume":"54","author":"Cheng","year":"2011","journal-title":"Diabetologia"},{"key":"ref_44","first-page":"1","article-title":"Plan and operation of the Third National Health and Nutrition Examination Survey, 1988\u20131994. Series 1: Programs and collection procedures","volume":"32","author":"Chyba","year":"1994","journal-title":"Vital. Health Stat 1"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.167.11.1159","article-title":"Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: Data from the Third National Health and Nutrition Examination Survey","volume":"167","author":"Martins","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjhyper.2007.01.017","article-title":"Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey","volume":"20","author":"Scragg","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10654-013-9790-2","article-title":"Vitamin D and risk of future hypertension: Meta-analysis of 283,537 participants","volume":"28","author":"Kunutsor","year":"2013","journal-title":"Eur. J. Epidemiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00125-008-1061-5","article-title":"The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide","volume":"51","author":"Mohr","year":"2008","journal-title":"Diabetologia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/HYPERTENSIONAHA.115.05319","article-title":"Effects of vitamin D on blood pressure and cardiovascular risk factors: A randomized controlled trial","volume":"65","author":"Pilz","year":"2015","journal-title":"Hypertension"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/CIRCULATIONAHA.114.011732","article-title":"Vitamin D therapy in individuals with prehypertension or hypertension: The DAYLIGHT trial","volume":"131","author":"Arora","year":"2015","journal-title":"Circulation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ajh.2012.111","article-title":"Effect of cholecalciferol supplementation during winter months in patients with hypertension: A randomized, placebo-controlled trial","volume":"25","author":"Larsen","year":"2012","journal-title":"Am. J. Hypertens."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jash.2014.12.019","article-title":"The effect of vitamin D supplementation on arterial stiffness in an elderly community-based population","volume":"9","author":"McGreevy","year":"2015","journal-title":"J. Am. Soc. Hypertens."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/HYPERTENSIONAHA.113.02177","article-title":"Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: Randomized, controlled trial","volume":"63","author":"Witham","year":"2014","journal-title":"Hypertension"},{"key":"ref_54","first-page":"1672","article-title":"Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: The VitDISH randomized controlled trial","volume":"173","author":"Witham","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2014.04.011","article-title":"Vitamin D and nifedipine in the treatment of Chinese patients with grades I-II essential hypertension: A randomized placebo-controlled trial","volume":"235","author":"Chen","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/MBP.0000000000000091","article-title":"The effect of vitamin D supplementation on blood pressure in patients with elevated blood pressure and vitamin D deficiency: A randomized, double-blind, placebo-controlled trial","volume":"20","author":"Loloei","year":"2015","journal-title":"Blood Press. Monit."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamainternmed.2015.0237","article-title":"Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data","volume":"175","author":"Beveridge","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1871529X14666140228122836","article-title":"Vitamin D and vitamin D receptor activators in treatment of hypertension and cardiovascular disease","volume":"14","author":"Franczyk","year":"2014","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1210\/jc.2013-1586","article-title":"Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: Implications for treatment and prophylaxis","volume":"98","author":"Cipriani","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/2\/455\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:53:41Z","timestamp":1760194421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/2\/455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,3]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2]]}},"alternative-id":["ijms19020455"],"URL":"https:\/\/doi.org\/10.3390\/ijms19020455","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,3]]}}}